Nicholas Mezitis is an Endocrinology/Metabolic physician affiliated with OhioHealth. OpenAlex indexes 25 publications with 704 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1818 Washington Blvd Ste F
Belpre, OH 457142080
Telephone
740-423-3640Provider last certified this registry record 10 Dec 2025.
Industry payments
23 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20252 payments
- Xeris Pharmaceuticals, Inc.Program year20252 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
56.7%GLP-1 receptor agonist16.3%Trulicity37%Mounjaro32%Ozempic31%Part D≥41 patientsSulfonylurea9.9%Glimepiride91%Glipizide Er5%Glipizide4%Part D<11 patients+ 12 more classes in this area
Hormonal (systemic)
23.1%l-Thyroxine20.5%Levothyroxine Sodium86%Synthroid15%Part D≥139 patientsThyroid Hormone Synthesis Inhibitor1.6%Methimazole100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
12.4%Statin2.8%Atorvastatin Calcium39%Rosuvastatin Calcium34%Simvastatin27%Part D<11 patientsCalcium channel blocker2.3%Amlodipine Besylate100%Part D≥20 patients+ 6 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Continuous Insulin Delivery Systems in the Management of Diabetes Mellitus
Contemporary Endocrinology
2024 - Diabetes insipidus in a patient with PCOS treated with Depo-Provera
Endocrinology Diabetes and Metabolism Case Reports
2022 - Glycemic Goals2017
Similar KOLs
Other experts from the same institution or the same specialty.
Yvonne Efebera, MD
OhioHealth
Gary Ansel, MD
OhioHealth
Michael A. Becker
OhioHealth
George R. Simon
OhioHealth
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”